Nonmyeloablative allogeneic stem cell transplantation for chronic lymphocytic leukaemia offers the possibility of disease control with minimal morbidity and mortality—a single institution experience
Crossref DOI link: https://doi.org/10.1007/s00277-015-2449-1
Published Online: 2015-08-12
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chakupurakal, G. http://orcid.org/0000-0002-7706-8447
Leitzke, S.
Langerbeins, P.
Schiller, J.
Schneider, P. M.
Holtick, U.
Shimabukuro-Vornhagen, A.
Theurich, S.
Chemnitz, J.
Hallek, M.
von Bergwelt-Baildon, M.
Scheid, C.
Text and Data Mining valid from 2015-08-12